Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 252, Supplement 1, pp S68–S72 | Cite as

Progress in the drug management of allergic rhinitis

  • N. Mygind
Review Article

Abstract

The diagnosis of allergic rhinitis is based on the case history, rhinoscopy and allergy testing. Therapy consists of allergen avoidance, pharmacotherapy, immunotherapy and/or surgery. This review deals only with pharmacotherapy, since there has been significant progress in this area. The first advance was the introduction of topical nasal steroids in the mid-1970s and the second the introduction of the second generation of H1 antihistamines in the early 1980s. The task for future developments is to optimize therapy by rational and combined use of available drugs, especially the steroid sprays and non-sedating antihistamines. A systematic approach to the choice of drug for the treatment of rhinitis is presented.

Key words

Allergic rhinitis Glucocorticosteroids Antihistamines 

References

  1. 1.
    Balle VH, Pedersen U, Engby B (1980) Allergic perennial and nonallergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology 18: 135–142PubMedGoogle Scholar
  2. 2.
    Borum P, Mygind N, Larsen FS (1979) Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. Clin Otolaryngol 4: 407–411PubMedGoogle Scholar
  3. 3.
    Borum P, Grønborg H, Mygind N (1987) Seasonal allergic rhinitis and depot injection of corticosteroid. Allergy 42: 26–32PubMedGoogle Scholar
  4. 4.
    Dolovich J, Mygind N (1993) Anticholinergic medication. In: Mygind N, Naclerio RM (eds) Allergic and non-allergic rhinitis: clinical aspects. Munksgaard, Copenhagen, pp 105–110Google Scholar
  5. 5.
    Howarth P (1993) Cromoglycate. In: Mygind N, Naclerio RM (eds) Allergic and non-allergic rhinitis: clinical aspects. Munksgaard, Copenhagen, pp 101–104Google Scholar
  6. 6.
    Lindgvist N, Andersson M, Bende M, Loeth S, Pipkorn U (1989) The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 19: 71–76CrossRefGoogle Scholar
  7. 7.
    Malm L, Änggård A (1993) Vasoconstrictors. In: Mygind N, Naclerio RM (eds) Allergic and non-allergic rhinitis: clinical aspects. Munksgaard, Copenhagen, pp 95–100Google Scholar
  8. 8.
    Mygind N (1993) Glucocorticosteroids and rhinitis. Allergy 48: 476–490PubMedGoogle Scholar
  9. 9.
    Mygind N, Naclerio RM (eds) (1989) Rhinoconjunctivitis: new perspectives in topical treatment. Hogrefe & Huber, Toronto, pp 1–52Google Scholar
  10. 10.
    Peck CC, Temple R, Collins JM (1993) Editorial. Understanding consequences of concurrent therapies. JAMA 269: 1550–1552PubMedCrossRefGoogle Scholar
  11. 11.
    Pedersen B, Larsen BB, Dahl R, Lindqvist N, Mygind N (1991) Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis. Allergy 46: 582–587PubMedGoogle Scholar
  12. 12.
    Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N (1982) Significance of H1 and H2 receptors in the human nose. J Allergy Clin Immunol 70: 211–218PubMedCrossRefGoogle Scholar
  13. 13.
    Simons FER (1993) Antihistamines. In: Mygind N, Naclerio RM (eds) Allergic and non-allergic rhinitis: clinical aspects. Munksgaard, Copenhagen, pp 123–136Google Scholar
  14. 14.
    Small P, Black M, Frenkiel S (1982) Effect of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 70: 78–82CrossRefGoogle Scholar
  15. 15.
    Soderberg-Warner ML (1984) Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 105: 840–841PubMedCrossRefGoogle Scholar
  16. 16.
    Tarlo SM, Cockroft DW, Dolovich J, Hargreave FE (1977) Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 59: 232–236PubMedCrossRefGoogle Scholar
  17. 17.
    Wihl J-Å, Petersen BN, Petersen BN, Gundersen G, Bresson K, Mygind N (1985) Effect of the non-sedating H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 75: 720–725PubMedCrossRefGoogle Scholar
  18. 18.
    Winther B, Brofeldt S, Borum P, Pedersen M, Mygind N (1983) Lack of effect on nasal discharge from a vasoconstrictor spray in common cold. Eur J Respir Dis 64 [Suppl 128]: 447–448Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • N. Mygind
    • 1
  1. 1.Department of Otorhinolaryngology, and Allergy Clinic, Department of Internal Medicine TTAOtopathological LaboratoryCopenhagenDenmark

Personalised recommendations